Who Just RaisedHealth Care · Ithaca, NYNew
Hypercell Technologies Inc.
Hypercell Technologies Inc. is a biotechnology company based in Ithaca, New York. In a Form D filed with the SEC on October 14, 2026, it reported raising $2,958,378 from 14 investors as part of an offering of up to $4,423,378. The first sale in the offering took place on September 8, 2026.
- 2nd Form D since 2021. Earlier new notices: Sep 10, 2021. All filings on EDGAR
- Still raising. $1.5M of the $4.4M offering was still unsold at filing.
$4.1M raised since 2020
2 Form D offerings, as reported to the SEC, the first in Sep 10, 2021. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 14, 2026 | $3M | $4.4M | 14 |
| Sep 10, 2021 | $1.1M | $1.8M | 6 |
Filing details
- Amount raised
- $2,958,378
- Offering size
- $4,423,378
- Investors so far
- 14
- Minimum investment
- $1
- First sale
- September 8, 2026
- Securities offered
- Equity, Options or warrants, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Ithaca, New York
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $2,958,378 | $4,423,378 | 14 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Similar raises
Frictionworx Inc.
Brooklyn, NY · filed Oct 13First Form DStill raising
Atmos Clinic, Inc.
New York, NY · filed Oct 8First Form DStill raising
PreciseDx, Inc.
New York, NY · filed Oct 7Current standards of care in oncology can be subjective, leading to a high percentage of tumors receiving intermediate grading. As a result, many patients are forced to anxiously await the results of…
3rd Form D since 2024
CAD Therapeutics, Inc.
New York, NY · filed Oct 2First Form DStill raising